Skip to content

Evidence Hub

Publication
Feb 14, 2023

iGlarLixi vs. premixed insulin initiation in adults with type 2 diabetes advancing from basal insulin therapy: SoliComplex real-world study

Aim To compare outcomes in adults with type 2 diabetes (T2D) suboptimally controlled with ...
Start Reading
Publication
Feb 14, 2023

Evaluation of VTE, MACE, and serious infections among patients with RA treated with baricitinib compared to TNFi: a multi-database study of patients in routine care using disease registries and claims

Introduction The aim of this work is to evaluate baricitinib safety with respect to ...
Start Reading
Publication
Feb 14, 2023

Effects of expanding the look‐back period to all available data in the assessment of covariates

Background A fixed baseline period has been a common covariate assessment approach in ...
Start Reading
Publication
Feb 14, 2023

Transferability of real-world data across borders for regulatory and health technology assessment decision-making

Recently, there has been increased consideration of real-world data (RWD) and real-world ...
Start Reading
Publication
Feb 14, 2023

Diagnosis-wide analysis of COVID-19 complications: an exposure-crossover study

Background: Many studies reporting coronavirus disease 2019 (COVID-19) complications have ...
Start Reading
Publication
Feb 14, 2023

Adherence to Chronic Kidney Disease Screening Guidelines Among Patients With Type 2 Diabetes in a US Administrative Claims Database

Objective To examine the screening rates for kidney damage and function among patients ...
Start Reading
Publication
Feb 14, 2023

SURF: A Screening tool (for manufacturers) to evaluate whether Using real-world data to support an effectiveness claim in an FDA application has Regulatory Feasibility

Based on recent guidance and publicly available approvals, the US Food and Drug ...
Start Reading
Publication
Feb 14, 2023

The Structured Process to Identify Fit-For-Purpose Data: A Data Feasibility Assessment Framework

To complement real-world evidence (RWE) guidelines, the 2019 Structured Preapproval and ...
Start Reading
Publication
Feb 14, 2023

Characteristics of adults newly diagnosed with idiopathic hypersomnia in the United States

Background Idiopathic hypersomnia is a debilitating sleep disorder; however, little is ...
Start Reading
Publication
Feb 14, 2023

[RCT-D] Non-randomized healthcare database studies and their agreement with 32 emulated randomized controlled trials

Importance Nonrandomized studies using insurance claims databases can be analyzed to ...
Start Reading
Publication
Feb 14, 2023

The Aetion Coalition to Advance Real-World Evidence through Randomized Controlled Trial Emulation (CARE) Initiative: Oncology

Legislative and technological advancements over the past decade have given rise to the ...
Start Reading
Publication
Feb 14, 2023

Drug utilization patterns and adherence in patients on systemic medications for the treatment of psoriasis: A retrospective, comparative cohort study

Background: Nonadherence to systemic treatments for psoriasis leads to treatment failure ...
Start Reading
Publication
Feb 14, 2023

Advancing digital health applications: priorities for innovation in real-world evidence generation

In 2019, Germany passed the Digital Healthcare Act, which, among other things, created a ...
Start Reading
Publication
Feb 14, 2023

"An epidemiological model to estimate the prevalence of diffuse large B-cell lymphoma in the United States"

Background: Prevalence is reflective of disease incidence and survival, and defined as ...
Start Reading
Publication
Feb 14, 2023

Single-arm oncology trials and the nature of external controls arms

Aim: Single-arm trials with external control arms (ECAs) have gained popularity in ...
Start Reading
Publication
Feb 14, 2023

Treatment Transitions in Chronic Obstructive Pulmonary Disease: Retrospective Analyses of US and UK Healthcare Databases

Introduction Previous studies have reported that more patients receive inhaled ...
Start Reading
Publication
Feb 14, 2023

Characteristics and outcomes of pregnancies in the Maternal Outcomes Masterset real-world database

Purpose Describe patient characteristics and pregnancy outcomes among all pregnant ...
Start Reading
Publication
Feb 14, 2023

Real-world data suggest antibody positivity to SARS-CoV-2 is associated with a decreased risk of future infection

Importance There is limited evidence regarding whether the presence of serum antibodies ...
Start Reading
Publication
Feb 14, 2023

Glucose‐lowering medications and the risk of cancer: a methodological review of studies based on real‐world data

Aim To review the methodology of observational studies examining the association between ...
Start Reading
Publication
Feb 14, 2023

The use of narrative electronic prescribing instructions in pharmacoepidemiology: A scoping review for the International Society for Pharmacoepidemiology

No link
Start Reading
Publication
Feb 14, 2023

Real-world evidence of stroke prevention in patients with nonvalvular atrial fibrillation in the United States: the REVISIT-US study

Background: Little data exists regarding the effectiveness and safety of rivaroxaban or ...
Start Reading
Publication
Feb 14, 2023

The role of real-world evidence in FDA-approved New Drug and Biologics License Applications

The US Food and Drug Administration (FDA) is open to accepting real-world evidence (RWE) ...
Start Reading
Publication
Feb 14, 2023

Real‐world evidence for assessing pharmaceutical treatments in the context of COVID‐19

The emergence and global spread of the severe acute respiratory syndrome coronavirus 2 ...
Start Reading
Publication
Feb 14, 2023

Duration of Protection Against SARS-CoV-2 Reinfection and Associated Risk of Reinfection Assessed with Real-World Data

This retrospective observational study aimed to gain a better understanding of the ...
Start Reading